Medizin: PCSK9 als neue Zielstruktur

ISSN： 2195-2175

Source： PHARMAKON, Vol.1, Iss.5, 2013-09, pp. : 372-373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Medizin Thrombozyten als Plasmodium -Killer

By Zündorf Ilse Dingermann Theo

PHARMAKON, Vol. 1, Iss. 2, 2013-03 ,pp. : 101-102

Govi-Verlag

Access to resources Recommend Favorite

PCSK9: an emerging target for treatment of hypercholesterolemia

By Duff Christopher J Hooper Nigel M

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 157-168

Informa Healthcare

Access to resources Recommend Favorite

Medizin Liquid Biopsy – Neue Wege in der Tumorforschung

By Zündorf Ilse

PHARMAKON, Vol. 4, Iss. 1, 2016-01 ,pp. : 5-7

Govi-Verlag

Access to resources Recommend Favorite

PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-01 ,pp. : 3869-3877

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-PCSK9 Antibodies: A New Era in the Treatment of Dyslipidemia

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1484-1494

Bentham Science Publishers

Access to resources Recommend Favorite